103 related articles for article (PubMed ID: 1280075)
1. Hepatitis C virus seroprevalence in the developmentally disabled.
Levinson WM; Wormser GP; Forseter G; Calmann M; O'Brien TA
Arch Intern Med; 1992 Nov; 152(11):2309-11. PubMed ID: 1280075
[TBL] [Abstract][Full Text] [Related]
2. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.
Thomas DL; Factor SH; Kelen GD; Washington AS; Taylor E; Quinn TC
Arch Intern Med; 1993 Jul; 153(14):1705-12. PubMed ID: 8333808
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of anti-HCV in an urban child population: a pilot survey in a developing area, Cameroon.
Ngatchu T; Stroffolini T; Rapicetta M; Chionne P; Lantum D; Chiaramonte M
J Trop Med Hyg; 1992 Feb; 95(1):57-61. PubMed ID: 1311043
[TBL] [Abstract][Full Text] [Related]
4. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey.
Akcam FZ; Uskun E; Avsar K; Songur Y
Int J Infect Dis; 2009 Mar; 13(2):274-84. PubMed ID: 18945630
[TBL] [Abstract][Full Text] [Related]
7. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community.
Barnes RE; Meyer RA; Gordon SC
Am J Gastroenterol; 1992 Aug; 87(8):1001-4. PubMed ID: 1379412
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
[TBL] [Abstract][Full Text] [Related]
11. Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.
Nakashima K; Kashiwagi S; Noguchi A; Hirata M; Hayashi J; Kawasaki T; Uezono K; Itoh K; Acharya GP; Ogata M
J Trop Med Hyg; 1995 Oct; 98(5):347-50. PubMed ID: 7563265
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
Vardas E; Sitas F; Seidel K; Casteling A; Sim J
Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus seroprevalence in patients attending a sexual health centre.
McKenna JG; Evans G; Lyttle PH; Couper A
N Z Med J; 1994 Jan; 107(970):8-10. PubMed ID: 7507582
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
Chan TM; Lok AS; Cheng IK; Chan RT
Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease.
Leslie DE; Rann S; Nicholson S; Fairley CK; Gust ID
Med J Aust; 1992 Jun; 156(11):789-92. PubMed ID: 1321326
[TBL] [Abstract][Full Text] [Related]
17. [The clinical usefulness of a new (the second generation) antibody to hepatitis C virus].
Kiyosawa K; Tanaka E; Sodeyama T; Furuta S; Kameko M; Katsuyama T
Rinsho Byori; 1992 Dec; 40(12):1245-51. PubMed ID: 1284913
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
19. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
20. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity.
Haushofer AC; Hauer R; Brunner H; Köller U; Trubert-Exinger D; Halbmayer WM; Koidl C; Kessler HH
J Clin Virol; 2004 Apr; 29(4):221-3. PubMed ID: 15018848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
